Your session is about to expire
← Back to Search
Behavioral Intervention
Remote Speech Rehabilitation for Dysarthria in Parkinson's Disease
N/A
Recruiting
Led By Yunjung Kim
Research Sponsored by Florida State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Medical diagnosis of PD
Age between 25 and 85
Must not have
Evidence of voice-speech disorders not-related to PD
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after and 6 months after treatment
Awards & highlights
No Placebo-Only Group
Summary
This trial focuses on a small study that includes participants from diverse linguistic and cultural backgrounds. Both patients with Parkinson's disease and their caregivers will receive speech therapy and counseling services. This trial aims to provide
Who is the study for?
This trial is for individuals with dysarthria, a speech disorder often associated with Parkinson's Disease. It aims to help those who face challenges in accessing traditional speech therapy due to linguistic and cultural barriers. Caregivers are also included to receive support.
What is being tested?
The study is testing remote speech rehabilitation services tailored for diverse populations. It focuses on providing accessible speech therapy and counseling that accounts for the participants' language and culture.
What are the potential side effects?
Since this trial involves non-medical interventions like remote speech therapy, there are no direct medical side effects expected. However, participants may experience fatigue or frustration during the rehabilitation process.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with Parkinson's disease.
Select...
I am between 25 and 85 years old.
Select...
I have no history of neurological diseases.
Select...
I have been diagnosed with speech difficulties due to Parkinson's by a speech therapist.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a voice or speech disorder not caused by Parkinson's disease.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately after and 6 months after treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after and 6 months after treatment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Speaking Rate (syl/s)
Speech Intelligibility Score on a Visual Analogue Scale
Vowel Space Area (kHz)
Secondary study objectives
Dysarthria Impact Profile (DIP)
Everyday Communication Measure
Perceived Stress Scale
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention: Behavioral, remote speech rehabilitation and counselingExperimental Treatment1 Intervention
Speech therapy will replicate the dose prescribed by many treatment programs including LSVT LOUD, LSVT ARTIC and Be Clear, consisting of 16 sessions of 50-60 minutes duration delivered over four weeks. Participants will also be set 15 to 20 minutes of daily home practice. Family education/training will take place once a week over 4 weeks, including two components: family counseling (30 min) and family conversation training (30 min). Family counseling aims to increase the PD families' knowledge about PD in general and to identify goals and potential solutions to problems which cause emotional turmoil. Family conversation training which aims to increase the PD families' knowledge about PD-related communication problems and to raise awareness of their communication patterns, and to support the development of functional strategies. All activities will remotely occur (using Zoom).
Group II: No Intervention:Waitlist controlActive Control1 Intervention
No intervention programs (speech therapy, counseling) will be provided.
Find a Location
Who is running the clinical trial?
Florida State UniversityLead Sponsor
221 Previous Clinical Trials
36,473 Total Patients Enrolled
Yunjung KimPrincipal InvestigatorFlorida State University
Share this study with friends
Copy Link
Messenger